Alexandria Hammond
Stock Analyst at B of A Securities
(0)
# 2870
Out of 5,291 analysts
14
Total ratings
50.00%
Success rate
5.53%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Akero Therapeutics | Upgrades: Buy | 35 63 | 42.66 | 47.68% | 2 | Jan 30, 2025 | |
Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | 637.75 | 80.32% | 1 | Nov 15, 2024 | |
Pfizer | Initiates Coverage On: Underperform | 25 | 25.19 | -0.75% | 1 | Nov 15, 2024 | |
Moderna | Initiates Coverage On: Underperform | 40 | 31.12 | 28.53% | 1 | Nov 15, 2024 | |
Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 1000 | 820.02 | 21.95% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | 163.6 | 16.14% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 111.78 | -1.59% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 205.15 | -0.07% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 327.91 | -54.26% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | 8.03 | 273.6% | 1 | Apr 22, 2024 |